Inactive ingredients include microcrystalline cellulose, magnesium stearate, and talc. Ninlaro is available in the following capsules Light orange gelatin capsule imprinted with takeda on the cap and 4 mg on the body in black ink Ninlaro (ixazomib capsules) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources. Find patient medical information for ninlaro (ixazomib) on webmd including its uses, side effects and safety, interactions, pictures, warnings, and user ratings The recommended starting ninlaro (ixazomib) dose is 4 mg (one capsule)
1 a 3 mg starting ninlaro (ixazomib) dose is recommended for patients with moderate or severe hepatic impairment and patients with severe renal impairment or esrd requiring dialysis 1 a 2.3 mg ninlaro (ixazomib) dose is also available for subsequent dose reductions due to. Proteasome inhibitors medically reviewed by philip thornton, dippharm Last updated on may 20, 2025 Uses warnings before taking dosage side effects interactions faq what is ninlaro Ninlaro is a cancer medicine that interferes with the growth and spread of cancer cells in the body
Ninlaro 4 mg hard capsules each capsule contains 4 mg of ixazomib (as 5.7 mg of ixazomib citrate) for the full list of excipients, see section 6.1. Learn about the ninlaroยฎ (ixazomib) treatment combination for multiple myeloma that has returned that may help you keep an active lifestyle See important safety information and prescribing information.
OPEN
